BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that twelve abstracts related to the Company’s clinical and preclinical development programs are scheduled for presentation and/or publication at the 48th Annual Meeting and Exposition of the American Society of Hematology (ASH) being held December 9-12, 2006, at the Orange County Convention Center in Orlando, FL.
